Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
378 News Items found
Ora Rosen
MSK Heroes
In honor of Women's History Month, meet the scientific hero who helped build MSK's molecular biology program.
Mathilde Krim
MSK Heroes
In honor of Women's History Month, meet the scientific hero who helped raise money and awareness for AIDS research.
MSK surgeons gathered around a robot used for cancer surgery
Q&A
Department of Surgery Chair Jeffrey Drebin discusses MSK’s approach to robotic surgery in response to a recent FDA advisory.
Enhanced MRI of a glioblastoma
In the Lab
MSK researchers have identified a compound that kills glioblastoma cells using a mechanism that’s completely different from earlier treatments.
Asia McCoy speaking with a patient
In the Clinic
In recent years, there has been a shift toward capturing information about the side effects caused by new treatments directly from patients.
Alex Kentsis in his lab
Finding
Researchers have found that the genetic changes that cause pediatric leukemia are different from those that lead to leukemia in adults.
A cartoon of a person hiding behind a newspaper and sunglasses.
In the Lab
CAR T Cells Get an Invisibility Cloak
Research is focusing on ways to help cancer-fighting immune cells stick around longer, boosting their effectiveness.
Colorful illustration of X and Y chromosome
In the Lab
A team from MSK is undertaking new research to study the genes found on the Y chromosome and their role in cancer.
Side-by-side pictures of tissues from a responder and a non-responder to targeted therapy for kidney cancer
Finding
One size does not fit all when it comes to treating renal cell carcinoma.
Microscopic image of prostate cancer cells in culture.
Q&A
Genetic sequencing of prostate tumors can identify men who should receive immunotherapy drugs.